Claim Missing Document
Check
Articles

Found 2 Documents
Search

Evaluation of Antioxidant Capacity, Alpha-Glucosidase inhibitor, and Chemical Profiling using HRMS UHPLC-Q-Orbitrap of Purslane (Portulaca oleracea L.) Extract Rizqi Nur Azizah; Fadlina Chany Saputri; Meidi Utami Puteri; Aktsar Roskiana Ahmad
EKSAKTA: Berkala Ilmiah Bidang MIPA Vol. 27 No. 05 (2026): Eksakta : Berkala Ilmiah Bidang MIPA (E-ISSN : 2549-7464) In Progress
Publisher : Faculty of Mathematics and Natural Sciences (FMIPA), Universitas Negeri Padang, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24036/eksakta/vol27-iss05/726

Abstract

Diabetes mellitus (DM), especially type 2, is a global health problem characterized by hyperglycemia. Oxidative stress is a major contributor to the complications of diabetes. One therapeutic strategy for managing type 2 DM is to inhibit the alpha-glucosidase enzyme. This study aims to investigate the antioxidant potential and alpha-glucosidase inhibitory activity of Portulaca oleracea L. extract, and to identify the phytochemical compounds responsible for these activities. This study was divided into 4 steps: (1) Extraction of purslane using 70% ethanol through UAE (2) Evaluation of antioxidant capacity (3) Alpha-Glucosidase Inhibitory Activity Test (4)  Quantitative screening was conducted to identify the presence of secondary metabolites using HRMS UHPLC-Q-Orbitrap. The research showed that the substance possesses antioxidant capacity, with an IC50 value of 40.41 µg/mL, and also has inhibitory effects against α-glucosidase, with an IC50 value of 229.41 µg/mL. The results of UHPLC-Q-Orbitrap mass spectrometry analysis of the 28 compounds found in the purslane extract identified flavonoids, polyphenols, alkaloids, fatty acids, terpenoids, and organic acids, including chromen-4-one, apigenin, nictoflorin, gallic acid, oleamide, 3,5-dioxooctanedioic acid, and 7-deoxyloganetin that contribute to alpha-glucosidase inhibition and correlated with antioxidant capacity. We conclude that purslane extract has potential as a natural antidiabetic agent.
Mechanism Activity and Spesific Chemical Compound of Purslane (Portulaca oleracea L.) in Managing Obesity: A Systematic Literature Review Rizqi Nur Azizah; Fadlina Chany Saputri; Meidi Utami Puteri; Aktsar Roskiana Ahmad
EKSAKTA: Berkala Ilmiah Bidang MIPA Vol. 27 No. 05 (2026): Eksakta : Berkala Ilmiah Bidang MIPA (E-ISSN : 2549-7464) In Progress
Publisher : Faculty of Mathematics and Natural Sciences (FMIPA), Universitas Negeri Padang, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24036/eksakta/vol27-iss05/734

Abstract

Obesity is global health problem characterized by an increase in body fat, leading to adverse metabolic, biomechanical, and psychosocial health consequences. Herbal supplementation have become increasingly popular due with fewer adverse effects and lower cost Previous study showed that Portulaca oleracea L. (PO) are one of the plants that can treating obesity. This revew demonstrates that PO exhibits potential as an alternative therapeutic agent in the management of obesity through multiple pharmacological mechanisms, including reduced weight gain & body fat, improved insulin sensitivity, reduced LDL-C, triglycerides, Improved weight, BMI, liver function with multiple mechanisms that can help manage obesity, primarily through its antioxidant, anti-inflammatory, and lipid & glucose methabolism regulation. These effects are associated with the synergistic action of its bioactive constituens, including homoisoflavonoids, oleracein E and oleracein L, omega-3 Fatty Acids (ALA), quercetin, rutin, and polyphenolic compound. The dose effevtive in animal studies is between 5%-10% extract PO for 12 weeks  and 500-700 mg for 4-8 weeks in clinical trial. This eview articles suggest a need for further, advanced-phase clinical trials in humans to establish an optimal and safe dosage for long-term use.